Dorzagliatin Chemical Structure, oral allosteric glucokinase activator - Hua Medicine, Shanghai, CN

oral allosteric glucokinase activator

Ph. III candidate in T2DM

HbA1c reduction vs placebo

Nat. Med.

Hua Medicine, Shanghai, CN

Context. Dorzagliatin (Hua Medicine) is an oral dual-acting full glucokinase (GK) activator being developed for type 2 diabetes. More than 50 years since the first report of the role…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.